{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:16:29Z","timestamp":1773908189080,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000387","name":"Meningitis UK","doi-asserted-by":"publisher","award":["6015"],"award-info":[{"award-number":["6015"]}],"id":[{"id":"10.13039\/501100000387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.07.032","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T18:56:43Z","timestamp":1437505003000},"page":"4486-4494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins"],"prefix":"10.1016","volume":"33","author":[{"given":"Miao-Chiu","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay R.","family":"Laver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Heckels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.032_bib0200","unstructured":"http:\/\/www.who.int\/vaccine_research\/diseases\/soa_bacterial\/en\/index1.html."},{"issue":"May (Suppl. 2)","key":"10.1016\/j.vaccine.2015.07.032_bib0205","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1016\/j.vaccine.2012.01.062","article-title":"Meningococcal vaccine development \u2013 from glycoconjugates against MenACWY to proteins against MenB \u2013 potential for broad protection against meningococcal disease","volume":"30","author":"Dull","year":"2012","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2015.07.032_bib0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12325-013-0032-5","article-title":"Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT","volume":"30","author":"Findlow","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"ii","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.07.032_bib0220","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2015.07.032_bib0225","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0230","unstructured":"https:\/\/www.gov.uk\/government\/groups\/joint-committee-on-vaccination-and-immunisation#publications-and-statements."},{"issue":"March (9923)","key":"10.1016\/j.vaccine.2015.07.032_bib0235","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(14)60226-9","article-title":"Group B meningococcal vaccine: recommendations for UK use","volume":"383","author":"Pollard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0240","unstructured":"http:\/\/www.cdc.gov\/meningococcal\/outbreaks\/vaccine-serogroupB.html."},{"key":"10.1016\/j.vaccine.2015.07.032_bib0245","series-title":"Thirteenth International Pathogenic Neisseria Conference","first-page":"116","article-title":"Identification of a novel vaccine candidate for group B Neisseria meningitidis","author":"Bernfield","year":"2002"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2015.07.032_bib0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of Factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"Mcneil","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.032_bib0255","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/INF.0b013e31827b0d24","article-title":"A randomized, controlled, phase 1\/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents","volume":"32","author":"Nissen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2015.07.032_bib0260","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0265","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"Bettinger","year":"2013","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2015.07.032_bib0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program","volume":"74","author":"O\u2019Ryan","year":"2014","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.vaccine.2015.07.032_bib0275","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/IAI.00701-09","article-title":"Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates","volume":"77","author":"Williams","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"Neisseria meningitidis serogroup B: laboratory correlates of protection","volume":"34","author":"Vermont","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"March (5459)","key":"10.1016\/j.vaccine.2015.07.032_bib0285","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2015.07.032_bib0290","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejcb.2011.12.004","article-title":"Crystal structures of receptors involved in small molecule transport across membranes","volume":"91","author":"Bulut","year":"2012","journal-title":"Eur J Cell Biol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2015.07.032_bib0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.53.1.229-233.1986","article-title":"A common neisserial antigen evidenced by immunization of mice with live Neisseria meningitidis","volume":"53","author":"Martin","year":"1986","journal-title":"Infect Immun"},{"issue":"October (8408)","key":"10.1016\/j.vaccine.2015.07.032_bib0300","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(84)90687-1","article-title":"Bactericidal antibodies against Neisseria gonorrhoeae elicited by Neisseria meningitidis","volume":"2","author":"Cremieux","year":"1984","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2015.07.032_bib0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0923-2508(92)90021-F","article-title":"Cloning and characterization of a Neisseria gene homologous to hisJ and argT of Escherichia coli and Salmonella typhimurium","volume":"143","author":"Lavitola","year":"1992","journal-title":"Res Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2015.07.032_bib0310","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/81380","article-title":"Functional genomics of Neisseria meningitidis pathogenesis","volume":"6","author":"Sun","year":"2000","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2015.07.032_bib0315","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/IAI.05019-11","article-title":"The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0320","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.032_bib0325","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00041-13","article-title":"The adhesin complex protein of Neisseria meningitidis is a new adhesin with vaccine potential","volume":"4","author":"Hung","year":"2013","journal-title":"mBIO"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2015.07.032_bib0330","first-page":"4881","article-title":"Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip\/H.8 and Laz lipoproteins","volume":"186","author":"Ray","year":"2011","journal-title":"J Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2015.07.032_bib0335","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2958.1995.mmi_17040675.x","article-title":"A third periplasmic transport system for L-arginine in Escherichia coli: molecular characterization of the artPIQMJ genes, arginine binding and transport","volume":"17","author":"Wissenbach","year":"1995","journal-title":"Mol Microbiol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2015.07.032_bib0340","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jmb.2007.10.049","article-title":"Crystal structures and mutational analysis of the arginine-, lysine-, histidine-binding protein ArtJ from Geobacillus stearothermophilus. Implications for interactions of ArtJ with its cognate ATP-binding cassette transporter, Art(MP)2","volume":"375","author":"Vahedi-Faridi","year":"2008","journal-title":"J Mol Biol"},{"issue":"September (39)","key":"10.1016\/j.vaccine.2015.07.032_bib0345","doi-asserted-by":"crossref","first-page":"30126","DOI":"10.1074\/jbc.M110.118513","article-title":"Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm","volume":"285","author":"Soriani","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0350","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jprot.2014.02.013","article-title":"Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis","volume":"101C","author":"Tsolakos","year":"2014","journal-title":"J Proteomics"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2015.07.032_bib0360","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"issue":"November (46)","key":"10.1016\/j.vaccine.2015.07.032_bib0365","doi-asserted-by":"crossref","first-page":"38383","DOI":"10.1074\/jbc.M508063200","article-title":"Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B","volume":"280","author":"Post","year":"2005","journal-title":"J Biol Chem"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2015.07.032_bib0370","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/IAI.01424-06","article-title":"Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant","volume":"75","author":"Williams","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.07.032_bib0375","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunisation with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2015.07.032_bib0380","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.vaccine.2013.03.033","article-title":"Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis","volume":"31","author":"Phillips","year":"2013","journal-title":"Vaccine"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2015.07.032_bib0385","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2015.07.032_bib0390","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T10:03:38Z","timestamp":1599300218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":39,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15009767"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}